Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test December 8, 2020December 9, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailQuantifying IgG is critical component to test population-wide vaccination effectiveness Related News: EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives…Thermo Fisher Scientific Launches Ion AmpliSeq…Roche obtains CE mark for the SARS-CoV-2 Antigen…Roche to launch SARS-CoV-2 & Flu A/B Rapid…Roche to introduce its next-generation portfolio of…PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
